373 related articles for article (PubMed ID: 35743639)
1. Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches.
Miserocchi G; Spadazzi C; Calpona S; De Rosa F; Usai A; De Vita A; Liverani C; Cocchi C; Vanni S; Calabrese C; Bassi M; De Luca G; Meccariello G; Ibrahim T; Schiavone M; Mercatali L
J Pers Med; 2022 May; 12(6):. PubMed ID: 35743639
[TBL] [Abstract][Full Text] [Related]
2. Head and neck cancer organoids as a promising tool for personalized cancer therapy: A literature review.
Mohtasham N; Mohajer Tehran F; Abbaszadeh H
Health Sci Rep; 2022 Apr; 5(3):e580. PubMed ID: 35387311
[TBL] [Abstract][Full Text] [Related]
3. Patient derived xenografts as models for head and neck cancer.
Nitschinsk K; Idris A; McMillan N
Cancer Lett; 2018 Oct; 434():114-119. PubMed ID: 30031118
[TBL] [Abstract][Full Text] [Related]
4. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
[TBL] [Abstract][Full Text] [Related]
5. Novel patient-derived preclinical models of liver cancer.
Bresnahan E; Ramadori P; Heikenwalder M; Zender L; Lujambio A
J Hepatol; 2020 Feb; 72(2):239-249. PubMed ID: 31954489
[TBL] [Abstract][Full Text] [Related]
6. Head and neck cancer patient-derived tumouroid cultures: opportunities and challenges.
Basnayake BWMTJ; Leo P; Rao S; Vasani S; Kenny L; Haass NK; Punyadeera C
Br J Cancer; 2023 May; 128(10):1807-1818. PubMed ID: 36765173
[TBL] [Abstract][Full Text] [Related]
7. The applications and techniques of organoids in head and neck cancer therapy.
Qi H; Tan X; Zhang W; Zhou Y; Chen S; Zha D; Wang S; Wen J
Front Oncol; 2023; 13():1191614. PubMed ID: 37427120
[TBL] [Abstract][Full Text] [Related]
8. Engineering models of head and neck and oral cancers on-a-chip.
da Costa Sousa MG; Vignolo SM; Franca CM; Mereness J; Alves Fraga MA; Silva-Sousa AC; Benoit DSW; Bertassoni LE
Biomicrofluidics; 2024 Mar; 18(2):021502. PubMed ID: 38464668
[TBL] [Abstract][Full Text] [Related]
9. Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension.
Miserocchi G; Bocchini M; Cortesi M; Arienti C; De Vita A; Liverani C; Mercatali L; Bravaccini S; Ulivi P; Zanoni M
Front Immunol; 2023; 14():1171141. PubMed ID: 37033986
[TBL] [Abstract][Full Text] [Related]
10. Approaches for Head and Neck Cancer Research - Current Status and the Way Forward.
V B; Femina T A; Iyengar D; K A; Ravi M
Cancer Invest; 2022 Feb; 40(2):151-172. PubMed ID: 34806936
[TBL] [Abstract][Full Text] [Related]
11. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling.
Dzobo K; Rowe A; Senthebane DA; AlMazyadi MAM; Patten V; Parker MI
OMICS; 2018 Dec; 22(12):733-748. PubMed ID: 30571609
[TBL] [Abstract][Full Text] [Related]
12. A review on the advances and challenges of immunotherapy for head and neck cancer.
Cheng G; Dong H; Yang C; Liu Y; Wu Y; Zhu L; Tong X; Wang S
Cancer Cell Int; 2021 Jul; 21(1):406. PubMed ID: 34332576
[TBL] [Abstract][Full Text] [Related]
13. Does the Microenvironment Hold the Hidden Key for Functional Precision Medicine in Pancreatic Cancer?
Kokkinos J; Jensen A; Sharbeen G; McCarroll JA; Goldstein D; Haghighi KS; Phillips PA
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34067833
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of B7-H3 as an opportunity for targeted therapy in head and neck cancers.
Hu J; Jiang C; Zheng M; Guo Y; Tang X; Ren J; Lu D; Yu L; Gan W; Liu S; Tong A; Yang H
Am J Transl Res; 2019; 11(8):5183-5196. PubMed ID: 31497233
[TBL] [Abstract][Full Text] [Related]
15. PCR-based zebrafish model for personalised medicine in head and neck cancer.
Al-Samadi A; Tuomainen K; Kivimäki A; Salem A; Al-Kubati S; Hyytiäinen A; Parikka M; Mesimäki K; Wilkman T; Mäkitie A; Grenman R; Salo T
J Transl Med; 2019 Jul; 17(1):235. PubMed ID: 31331338
[TBL] [Abstract][Full Text] [Related]
16.
Seliger B; Al-Samadi A; Yang B; Salo T; Wickenhauser C
Front Med (Lausanne); 2022; 9():971726. PubMed ID: 36160162
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers.
Fan C; Wang J; Tang Y; Zhang S; Xiong F; Guo C; Zhou Y; Li Z; Li X; Li Y; Li G; Zeng Z; Xiong W
BMC Cancer; 2020 Sep; 20(1):917. PubMed ID: 32972383
[TBL] [Abstract][Full Text] [Related]
18. The Promise of Patient-Derived Preclinical Models to Accelerate the Implementation of Personalised Medicine for Children with Neuroblastoma.
Tucker ER; George S; Angelini P; Bruna A; Chesler L
J Pers Med; 2021 Mar; 11(4):. PubMed ID: 33808071
[TBL] [Abstract][Full Text] [Related]
19. Osteomimetic matrix components alter cell migration and drug response in a 3D tumour-engineered osteosarcoma model.
Pavlou M; Shah M; Gikas P; Briggs T; Roberts SJ; Cheema U
Acta Biomater; 2019 Sep; 96():247-257. PubMed ID: 31302294
[TBL] [Abstract][Full Text] [Related]
20. Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers.
Shaikh MH; Idris A; Johnson NW; Fallaha S; Clarke DTW; Martin D; Morgan IM; Gabrielli B; McMillan NAJ
Oral Oncol; 2018 Nov; 86():105-112. PubMed ID: 30409290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
